AbbVie Inc.
1 North Waukegan Road
North Chicago, IL 60064-6400
United States
847 932 7900
https://www.abbvie.com
版塊: Healthcare
行業: Drug Manufacturers - General
全職員工: 50,000
高階主管
| 名稱 | 頭銜 | 支付 | 行使價 | 出生年份 |
|---|---|---|---|---|
| Mr. Richard A. Gonzalez | Chairman & CEO | 7.19M | 無 | 1954 |
| Mr. Robert A. Michael | President & COO | 4.62M | 無 | 1970 |
| Mr. Scott T. Reents | Executive VP & CFO | 3.13M | 無 | 1968 |
| Dr. Azita Saleki-Gerhardt Ph.D. | Executive VP & COO | 3.51M | 5.25M | 1963 |
| Mr. Jeffrey Ryan Stewart | Executive VP & Chief Commercial Officer | 4.32M | 2.13M | 1969 |
| Dr. Thomas J. Hudson M.D. | Senior VP & Chief Scientific Officer of Global Research | 無 | 無 | 1962 |
| Ms. Elizabeth Shea | Senior Vice President of Investor Relations | 無 | 無 | 無 |
| Mr. Perry C. Siatis | Executive VP, General Counsel & Secretary | 無 | 無 | 1975 |
| Mr. Sanjay Narayan | Senior VP, Chief Ethics, Compliance Officer & Allergan Aesthetic Legal | 無 | 無 | 無 |
| Mr. Timothy J. Richmond | Executive VP & Chief Human Resources Officer | 1.12M | 無 | 1966 |
描述
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.
公司管治
截至 2024年4月1日 止，AbbVie Inc. 的 ISS 管治質素評分為 8。 Pillar 分數正在審核中：8；董事會：5；股東權利：9；現金賠償：6。
